Literature DB >> 21997623

Pharmacogenetics and the immunogenicity of protein therapeutics.

Chen Yanover, Nisha Jain, Glenn Pierce, Tom E Howard, Zuben E Sauna.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21997623     DOI： 10.1038/nbt.2002

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  19 in total

Review 1.  Scientific and regulatory considerations on the immunogenicity of biologics.

Authors:  Gopi Shankar; Elizabeth Shores; Carrie Wagner; Anthony Mire-Sluis
Journal:  Trends Biotechnol       Date:  2006-05-02       Impact factor: 19.536

2.  Signatures of demographic history and natural selection in the human major histocompatibility complex Loci.

Authors:  Diogo Meyer; Richard M Single; Steven J Mack; Henry A Erlich; Glenys Thomson
Journal:  Genetics       Date:  2006-05-15       Impact factor: 4.562

Review 3.  Genetic risk factors for inhibitors to factors VIII and IX.

Authors:  J Oldenburg; A Pavlova
Journal:  Haemophilia       Date:  2006-12       Impact factor: 4.287

Review 4.  Prediction of immunogenicity of therapeutic proteins: validity of computational tools.

Authors:  Christine J Bryson; Tim D Jones; Matthew P Baker
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

5.  Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Authors:  Jinhai Wang; Jay Lozier; Gibbes Johnson; Susan Kirshner; Daniela Verthelyi; Anne Pariser; Elizabeth Shores; Amy Rosenberg
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

Review 6.  Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factors.

Authors:  Suryasarathi Dasgupta; Ana-Maria Navarrete; Sandrine Delignat; Bharath Wootla; Sebastien Andre; Valakunja Nagaraja; Sebastien Lacroix-Desmazes; Srinivas V Kaveri
Journal:  Immunol Lett       Date:  2007-04-13       Impact factor: 3.685

7.  A second generation human haplotype map of over 3.1 million SNPs.

Authors:  Kelly A Frazer; Dennis G Ballinger; David R Cox; David A Hinds; Laura L Stuve; Richard A Gibbs; John W Belmont; Andrew Boudreau; Paul Hardenbol; Suzanne M Leal; Shiran Pasternak; David A Wheeler; Thomas D Willis; Fuli Yu; Huanming Yang; Changqing Zeng; Yang Gao; Haoran Hu; Weitao Hu; Chaohua Li; Wei Lin; Siqi Liu; Hao Pan; Xiaoli Tang; Jian Wang; Wei Wang; Jun Yu; Bo Zhang; Qingrun Zhang; Hongbin Zhao; Hui Zhao; Jun Zhou; Stacey B Gabriel; Rachel Barry; Brendan Blumenstiel; Amy Camargo; Matthew Defelice; Maura Faggart; Mary Goyette; Supriya Gupta; Jamie Moore; Huy Nguyen; Robert C Onofrio; Melissa Parkin; Jessica Roy; Erich Stahl; Ellen Winchester; Liuda Ziaugra; David Altshuler; Yan Shen; Zhijian Yao; Wei Huang; Xun Chu; Yungang He; Li Jin; Yangfan Liu; Yayun Shen; Weiwei Sun; Haifeng Wang; Yi Wang; Ying Wang; Xiaoyan Xiong; Liang Xu; Mary M Y Waye; Stephen K W Tsui; Hong Xue; J Tze-Fei Wong; Luana M Galver; Jian-Bing Fan; Kevin Gunderson; Sarah S Murray; Arnold R Oliphant; Mark S Chee; Alexandre Montpetit; Fanny Chagnon; Vincent Ferretti; Martin Leboeuf; Jean-François Olivier; Michael S Phillips; Stéphanie Roumy; Clémentine Sallée; Andrei Verner; Thomas J Hudson; Pui-Yan Kwok; Dongmei Cai; Daniel C Koboldt; Raymond D Miller; Ludmila Pawlikowska; Patricia Taillon-Miller; Ming Xiao; Lap-Chee Tsui; William Mak; You Qiang Song; Paul K H Tam; Yusuke Nakamura; Takahisa Kawaguchi; Takuya Kitamoto; Takashi Morizono; Atsushi Nagashima; Yozo Ohnishi; Akihiro Sekine; Toshihiro Tanaka; Tatsuhiko Tsunoda; Panos Deloukas; Christine P Bird; Marcos Delgado; Emmanouil T Dermitzakis; Rhian Gwilliam; Sarah Hunt; Jonathan Morrison; Don Powell; Barbara E Stranger; Pamela Whittaker; David R Bentley; Mark J Daly; Paul I W de Bakker; Jeff Barrett; Yves R Chretien; Julian Maller; Steve McCarroll; Nick Patterson; Itsik Pe'er; Alkes Price; Shaun Purcell; Daniel J Richter; Pardis Sabeti; Richa Saxena; Stephen F Schaffner; Pak C Sham; Patrick Varilly; David Altshuler; Lincoln D Stein; Lalitha Krishnan; Albert Vernon Smith; Marcela K Tello-Ruiz; Gudmundur A Thorisson; Aravinda Chakravarti; Peter E Chen; David J Cutler; Carl S Kashuk; Shin Lin; Gonçalo R Abecasis; Weihua Guan; Yun Li; Heather M Munro; Zhaohui Steve Qin; Daryl J Thomas; Gilean McVean; Adam Auton; Leonardo Bottolo; Niall Cardin; Susana Eyheramendy; Colin Freeman; Jonathan Marchini; Simon Myers; Chris Spencer; Matthew Stephens; Peter Donnelly; Lon R Cardon; Geraldine Clarke; David M Evans; Andrew P Morris; Bruce S Weir; Tatsuhiko Tsunoda; James C Mullikin; Stephen T Sherry; Michael Feolo; Andrew Skol; Houcan Zhang; Changqing Zeng; Hui Zhao; Ichiro Matsuda; Yoshimitsu Fukushima; Darryl R Macer; Eiko Suda; Charles N Rotimi; Clement A Adebamowo; Ike Ajayi; Toyin Aniagwu; Patricia A Marshall; Chibuzor Nkwodimmah; Charmaine D M Royal; Mark F Leppert; Missy Dixon; Andy Peiffer; Renzong Qiu; Alastair Kent; Kazuto Kato; Norio Niikawa; Isaac F Adewole; Bartha M Knoppers; Morris W Foster; Ellen Wright Clayton; Jessica Watkin; Richard A Gibbs; John W Belmont; Donna Muzny; Lynne Nazareth; Erica Sodergren; George M Weinstock; David A Wheeler; Imtaz Yakub; Stacey B Gabriel; Robert C Onofrio; Daniel J Richter; Liuda Ziaugra; Bruce W Birren; Mark J Daly; David Altshuler; Richard K Wilson; Lucinda L Fulton; Jane Rogers; John Burton; Nigel P Carter; Christopher M Clee; Mark Griffiths; Matthew C Jones; Kirsten McLay; Robert W Plumb; Mark T Ross; Sarah K Sims; David L Willey; Zhu Chen; Hua Han; Le Kang; Martin Godbout; John C Wallenburg; Paul L'Archevêque; Guy Bellemare; Koji Saeki; Hongguang Wang; Daochang An; Hongbo Fu; Qing Li; Zhen Wang; Renwu Wang; Arthur L Holden; Lisa D Brooks; Jean E McEwen; Mark S Guyer; Vivian Ota Wang; Jane L Peterson; Michael Shi; Jack Spiegel; Lawrence M Sung; Lynn F Zacharia; Francis S Collins; Karen Kennedy; Ruth Jamieson; John Stewart
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

8.  Inhibitors of factor VIII in black patients with hemophilia.

Authors:  Kevin R Viel; Afshin Ameri; Thomas C Abshire; Rathi V Iyer; Raymond G Watts; Charles Lutcher; Cynthia Channell; Shelley A Cole; Karl M Fernstrom; Shelley Nakaya; Carol K Kasper; Arthur R Thompson; Laura Almasy; Tom E Howard
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

9.  Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti-factor VIII immune responses.

Authors:  Ruth A Ettinger; Eddie A James; William W Kwok; Arthur R Thompson; Kathleen P Pratt
Journal:  Blood       Date:  2009-06-23       Impact factor: 22.113

10.  A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach.

Authors:  Peng Wang; John Sidney; Courtney Dow; Bianca Mothé; Alessandro Sette; Bjoern Peters
Journal:  PLoS Comput Biol       Date:  2008-04-04       Impact factor: 4.475
View more
  7 in total

Review 1.  Recent Advances in Application of Pharmacogenomics for Biotherapeutics.

Authors:  Pramod B Mahajan
Journal:  AAPS J       Date:  2016-03-23       Impact factor: 4.009

Review 2.  The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics.

Authors:  Zuben E Sauna; Jay N Lozier; Carol K Kasper; Chen Yanover; Timothy Nichols; Tom E Howard
Journal:  Blood       Date:  2014-11-18       Impact factor: 22.113

3.  HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.

Authors:  Christian A Fernandez; Colton Smith; Wenjian Yang; Mihir Daté; Donald Bashford; Eric Larsen; W Paul Bowman; Chengcheng Liu; Laura B Ramsey; Tamara Chang; Victoria Turner; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Suna Onengut-Gumuscu; Wei-Min Chen; Patrick Concannon; Stephen S Rich; Paul Scheet; Sima Jeha; Ching-Hon Pui; William E Evans; Meenakshi Devidas; Mary V Relling
Journal:  Blood       Date:  2014-06-26       Impact factor: 22.113

4.  De novo design of functional zwitterionic biomimetic material for immunomodulation.

Authors:  Bowen Li; Zhefan Yuan; Priyesh Jain; Hsiang-Chieh Hung; Yuwei He; Xiaojie Lin; Patrick McMullen; Shaoyi Jiang
Journal:  Sci Adv       Date:  2020-05-29       Impact factor: 14.136

5.  Immunogenicity Risk Profile of Nanobodies.

Authors:  Chloé Ackaert; Natalia Smiejkowska; Catarina Xavier; Yann G J Sterckx; Sofie Denies; Benoit Stijlemans; Yvon Elkrim; Nick Devoogdt; Vicky Caveliers; Tony Lahoutte; Serge Muyldermans; Karine Breckpot; Marleen Keyaerts
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

6.  Allelic variation in HLA-DRB1 is associated with development of antidrug antibodies in cancer patients treated with atezolizumab that are neutralizing in vitro.

Authors:  Christian Hammer; Jane Ruppel; Lynn Kamen; Julie Hunkapiller; Ira Mellman; Valerie Quarmby
Journal:  Clin Transl Sci       Date:  2022-04-08       Impact factor: 4.438

7.  Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.

Authors:  Gouri Shankar Pandey; Chen Yanover; Lisa M Miller-Jenkins; Susan Garfield; Shelley A Cole; Joanne E Curran; Eric K Moses; Natalia Rydz; Vijaya Simhadri; Chava Kimchi-Sarfaty; David Lillicrap; Kevin R Viel; Teresa M Przytycka; Glenn F Pierce; Tom E Howard; Zuben E Sauna
Journal:  Nat Med       Date:  2013-09-15       Impact factor: 53.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.